Relevance of KDPI value and acute rejection on kidney transplant outcomes in recipients with delayed graft function - a retrospective study.


Journal

Transplant international : official journal of the European Society for Organ Transplantation
ISSN: 1432-2277
Titre abrégé: Transpl Int
Pays: Switzerland
ID NLM: 8908516

Informations de publication

Date de publication:
09 2020
Historique:
received: 02 12 2019
revised: 20 01 2020
accepted: 11 05 2020
pubmed: 18 5 2020
medline: 25 6 2021
entrez: 18 5 2020
Statut: ppublish

Résumé

Delayed graft function (DGF) is associated with poorer graft survival and higher rate of acute rejection (AR). It is unknown whether this negative influence relies on the increased risk of AR or the DGF itself. The different Kidney Donor Profile Index (KDPI) values may also play a role in this interaction. Retrospective study aimed to evaluate the impact of DGF on graft function and graft survival in a subset of KT recipients (2004-2017). We also analyzed the relationship between KDPI and DGF. The study includes 601 KT, 226 of them (37%) developed DGF. Graft survival was lower in patients with DGF compared with non-DGF patients. Multivariable analysis revealed DGF as risk factor for graft loss, independently of the presence or not of acute rejection. Between DGF patients, we observed poorer graft survival in patients with higher KDPI value (>85%). We observed a trend of a greater impact of KDPI in patients with DGF, although this interaction was not statistically significant. Additionally, we observed poorer 12-month graft function in DGF patients. DGF is related to poorer graft survival independently of the developed acute rejection. This negative impact might be influenced by high KDPI values.

Identifiants

pubmed: 32418259
doi: 10.1111/tri.13654
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1071-1077

Subventions

Organisme : Instituto de Salud Carlos III
ID : CM17/00067
Organisme : FIS-FEDERER
ID : FIS-FEDER PI16/0617
Organisme : RedinRed
ID : RD16/0009/0013

Informations de copyright

© 2020 Steunstichting ESOT. Published by John Wiley & Sons Ltd.

Références

Yarlagadda SG, Coca SG, Garg AX, et al. Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrol Dial Transplant 2008; 23: 2995.
Irish WD, Ilsley JN, Schnitzler MA, Feng S, Brennan DC. A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant. 2010; 10: 2279.
Portolés JM, Pérez-Sáez MJ, López-Sánchez P, et al. Trasplante renal con órganos procedentes de donación tras parada circulatoria controlada: resultados del estudio multicéntrico GEODAS-3. Nefrología. 2019; 39: 151.
On behalf of the GEODAS Group, Pérez-SáezM J, Lafuente Covarrubias O, et al. Early outcomes of kidney transplantation from elderly donors after circulatory death (GEODAS study). BMC Nephrol 2019;20:233.
Akkina SK, Connaire JJ, Israni AK, Snyder JJ, Matas AJ, Kasiske BL. Similar outcomes with different rates of delayed graft function may reflect center practice, not center performance. Am J Transplant 2009; 9: 1460.
Siedlecki A, Irish W, Brennan DC. Delayed graft function in the kidney transplant: delayed graft function in the kidney transplant. Am J Transplant 2011; 11: 2279.
Eltzschig HK, Eckle T. Ischemia and reperfusion-from mechanism to translation. Nat Med 2011; 17: 1391.
Yarlagadda SG, Coca SG, Formica RN, Poggio ED, Parikh CR. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant 2008; 24: 1039.
Wu WK, Famure O, Li Y, Kim SJ. Delayed graft function and the risk of acute rejection in the modern era of kidney transplantation. Kidney Int 2015; 88: 851.
Moreso F. Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients. Nephrol Dial Transplant 1999; 14: 930.
Feldman HI, Gayner R, Berlin JA, et al. Delayed function reduces renal allograft survival independent of acute rejection. Nephrol Dial Transplant 1996; 11: 1306.
Shoskes DA, Cecka JM. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection1,2,3. Transplantation 1998; 66: 1697.
Troppmann C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. Transplantation 1995; 59: 962.
Mikhalski D, Wissing KM, Ghisdal L, et al. ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. Transplantation 2008; 85(Supplement): S3.
Zens TJ, Danobeitia JS, Leverson G, et al. The impact of kidney donor profile index on delayed graft function and transplant outcomes: A single-center analysis. Clin Transplant 2018; 32: e13190.
A Guide to Calculating and Interpreting the Kidney Donor Profle Index (KDPI). Available from: https://optn.transplant.hrsa.gov/resources/guidance/kidney-donor-profile-index-kdpi-guide-for-clinicians/
Fernández-Juarez G, Marcén R, Pascual J, et al. Prolonged delayed graft function decreases graft survival in transplant patients taking cyclosporine. Transplant Proc 2002; 34: 338.
Pérez-Sáez MJ, Montero N, Redondo-Pachón D, Crespo M, Pascual J. Strategies for an expanded use of kidneys from elderly donors. Transplantation 2017; 101: 727.
Boom H, Mallat MJK, De Fijter JW, Zwinderman AH, Paul LC. Delayed graft function influences renal function, but not survival. Kidney Int 2000; 58: 859.
Wang CJ, Tuffaha A, Phadnis MA, Mahnken JD, Wetmore JB. Association of slow graft function with long-term outcomes in kidney transplant recipients. Ann Transplant 2018; 23: 224.
Johnston O, O’Kelly P, Spencer S, et al. Reduced graft function (with or without dialysis) vs immediate graft function-a comparison of long-term renal allograft survival. Nephrol Dial Transplant 2006; 21: 2270.
Hernández D, Rufino M, González-Posada JM, et al. Predicting delayed graft function and mortality in kidney transplantation. Transplant Rev 2008; 22: 21.

Auteurs

Carlos E Arias-Cabrales (CE)

Nephrology, Hospital del Mar, Barcelona, Spain.

María José Pérez-Sáez (MJ)

Nephrology, Hospital del Mar, Barcelona, Spain.

Dolores Redondo-Pachón (D)

Nephrology, Hospital del Mar, Barcelona, Spain.

Anna Buxeda (A)

Nephrology, Hospital del Mar, Barcelona, Spain.

Carla Burballa (C)

Nephrology, Hospital del Mar, Barcelona, Spain.

Xavier Duran (X)

Methodological and Biostatistics consultancy, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.

Marisa Mir (M)

Nephrology, Hospital del Mar, Barcelona, Spain.

Marta Crespo (M)

Nephrology, Hospital del Mar, Barcelona, Spain.

Julio Pascual (J)

Nephrology, Hospital del Mar, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH